The Innovator IBD 50 ETF is headed for a week of outstanding gains. Three stocks in the ETF are near buy points.

Over 100 years of market history reveals that the best stocks typically have an 80 or better RS Rating as they begin their ...

Royal Caribbean announces 36% dividend hike, $1 billion share repurchase plan. RCL stock looks to retake a buy point.

Patients with inflammatory bowel disease remain at higher risk for mental health disorders, but training support staff to ...

In a recent study published in the Journal of Crohn’s and Colitis, researchers showed that oral vancomycin (OV) induces ...

Leading specialists discuss the increasing prevalence of colorectal diseases in India, highlighting modern treatment ...

Samsara is the IBD Stock of the Day ahead of its Q4 earnings report due March 6. Samara stock has forged a cup base, rebounding from a sell-off.

Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

The most common reason for delaying or not receiving care was not getting an appointment when they needed one, cited by 39% of respondents. More than half (56%) of patients reported delays in ...

Past research shows that it can be challenging to detect pre-cancerous cells in people with IBD. Researchers from The ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...